GPA33 and neoplasm: For the GPA33 (nonspecific) 225Ac-PRIT group, this occurred at 23 d despite weight losses of 9% and 4% from pretreatment baseline (tumor volumes at 16 d, 95.1 and 43.5 mm3, respectively).